Related Experiment Video
Updated: Jul 12, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
Published on: February 27, 2016
Function of the SIRT1 protein deacetylase in cancer
Walter Stünkel1, Bee Keow Peh, Yong Cheng Tan
1S*BIO PTE Ltd, 1 Singapore Science Park II, Singapore, Singapore.
Abstract:
The NAD(+)-dependent protein deacetylase SIRT1 is linked to cellular survival pathways by virtue of keeping the tumor suppressor gene p53 and members of the forkhead transcription factor family deacetylated. To validate SIRT1 as a therapeutic anti-cancer target, we performed immunohistochemistry experiments to study the in vivo expression of SIRT1 in cancer specimens. We show that human SIRT1 is highly expressed in cancer cell lines as well as in tissue samples from colon carcinoma patients. Interestingly, there is a strong cytosolic component in the SIRT1 expression pattern. We further characterized SIRT1 in p53-wild-type and -mutant cell lines and show that SIRT1 mRNA-knockdown leads to a p53-independent decrease of cell proliferation and induction of apoptosis. In addition, SIRT1 expression has been found to be inducible upon DNA damage. A previously discovered small molecule SIRT1 inhibitor with nanomolar in vitro activity has been tested in cancer relevant assays. The SIRT1 inhibitory compound showed no potent anti-proliferative activity despite hitting its molecular target within tumor cells. From these studies we conclude that it may not be sufficient to block the catalytic function of SIRT1, and that its survival effects may be mainly brought about by means other then the deacetylase function. The increased cytosolic expression of SIRT1 in cancer cells could be an indicator of such novel functions.
Insights
Sirtuin 1 (SIRT1) is highly expressed in colon cancer, but inhibiting its deacetylase function alone did not reduce proliferation. Novel functions beyond deacetylation may drive cancer cell survival.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Sirtuin 1 (SIRT1) deacetylates tumor suppressors like p53, linking it to cellular survival.
- Validating SIRT1 as an anti-cancer target requires understanding its in vivo expression and function.
Purpose of the Study:
- To investigate the in vivo expression of SIRT1 in cancer specimens.
- To determine the role of SIRT1's deacetylase activity in cancer cell proliferation and apoptosis.
- To evaluate the efficacy of a small molecule SIRT1 inhibitor in cancer-relevant assays.
Main Methods:
- Immunohistochemistry on human cancer specimens and cell lines.
- SIRT1 mRNA knockdown in p53-wild-type and -mutant cell lines.
- Assays to assess cell proliferation, apoptosis, and inhibitor activity.
Main Results:
- Human SIRT1 is highly expressed in cancer cell lines and colon carcinoma tissues, with significant cytosolic localization.
- SIRT1 mRNA knockdown reduced cell proliferation and induced apoptosis independently of p53 status.
- A small molecule SIRT1 inhibitor showed limited anti-proliferative effects despite target engagement.
Conclusions:
- SIRT1's deacetylase function may not be sufficient to explain its role in cancer cell survival.
- Novel, non-deacetylase functions of SIRT1, potentially linked to its cytosolic expression, may drive cancer progression.
- Targeting SIRT1 may require strategies beyond inhibiting its catalytic activity.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...